Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

Serum tryptase monitoring in indolent systemic mastocytosis: association with disease features and patient outcome.

BACKGROUND: Serum baseline tryptase (sBT) is a minor diagnostic criterion for systemic mastocytosis (SM) of undetermined prognostic impact. We monitored sBT levels in indolent SM (ISM) patients and investigated its utility for predicting disease behaviour and outcome. METHODS: In total 74 adult ISM...

Full description

Bibliographic Details
Main Authors: Almudena Matito, José Mario Morgado, Iván Álvarez-Twose, Laura Sánchez-Muñoz, Carlos Eduardo Pedreira, María Jara-Acevedo, Cristina Teodosio, Paula Sánchez-López, Elisa Fernández-Núñez, Ricardo Moreno-Borque, Andrés García-Montero, Alberto Orfao, Luis Escribano
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3796517?pdf=render

Internet

http://europepmc.org/articles/PMC3796517?pdf=render

Similar Items